Literature DB >> 12453430

RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators.

Reuben S Harris1, Svend K Petersen-Mahrt, Michael S Neuberger.   

Abstract

APOBEC1 is the catalytic component of an RNA editing complex but shows homology to activation-induced cytidine deaminase (AID), a protein whose function is to potentiate diversification of immunoglobulin gene DNA. Here, we show that APOBEC1 and its homologs APOBEC3C and APOBEC3G exhibit potent DNA mutator activity in an E. coli assay. Indeed, like AID, these proteins appear to trigger DNA mutation through dC deamination. However, each protein exhibits a distinct local target sequence specificity. The results reveal the existence of a family of potential active dC/dG mutators, with possible implications for cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12453430     DOI: 10.1016/s1097-2765(02)00742-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  236 in total

1.  Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

Authors:  Wenyan Zhang; Juan Du; Kevin Yu; Tao Wang; Xiong Yong; Xiao-Fang Yu
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells.

Authors:  Kerri E Rieger; Gilbert Chu
Journal:  Nucleic Acids Res       Date:  2004-09-08       Impact factor: 16.971

3.  The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activity.

Authors:  Marcel Ooms; Susan Majdak; Christopher W Seibert; Ariana Harari; Viviana Simon
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

4.  Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.

Authors:  Ashok S Bhagwat; Weilong Hao; Jesse P Townes; Heewook Lee; Haixu Tang; Patricia L Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-02       Impact factor: 11.205

Review 5.  Single-nucleotide editing: From principle, optimization to application.

Authors:  Jinling Tang; Trevor Lee; Tao Sun
Journal:  Hum Mutat       Date:  2019-09-15       Impact factor: 4.878

6.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

7.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

8.  Alternative induction of meiotic recombination from single-base lesions of DNA deaminases.

Authors:  Siim Pauklin; Julia S Burkert; Julie Martin; Fekret Osman; Sandra Weller; Simon J Boulton; Matthew C Whitby; Svend K Petersen-Mahrt
Journal:  Genetics       Date:  2009-02-23       Impact factor: 4.562

Review 9.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

Review 10.  Clonal expansion in non-cancer tissues.

Authors:  Nobuyuki Kakiuchi; Seishi Ogawa
Journal:  Nat Rev Cancer       Date:  2021-02-24       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.